Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Magnesium in headache.

Yablon LA, Mauskop A.

In: Vink R, Nechifor M, editors. Magnesium in the Central Nervous System [Internet]. Adelaide (AU): University of Adelaide Press; 2011.

2.

Stem Cells in the Treatment of Refractory Chronic Migraines.

Mauskop A, Rothaus KO.

Case Rep Neurol. 2017 Jun 14;9(2):149-155. doi: 10.1159/000477393. eCollection 2017 May-Aug.

3.

Nutraceuticals in Acute and Prophylactic Treatment of Migraine.

Daniel O, Mauskop A.

Curr Treat Options Neurol. 2016 Apr;18(4):14. doi: 10.1007/s11940-016-0398-1.

PMID:
26923604
4.

Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study.

Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA.

Cephalalgia. 2014 Oct;34(12):986-93. doi: 10.1177/0333102414524494. Epub 2014 Mar 7.

PMID:
24607501
5.

Vagus nerve stimulation for refractory cluster headaches.

Mauskop A.

Headache. 2014 Jan;54(1):170. doi: 10.1111/head.12244. No abstract available.

PMID:
24400761
7.

Complementary and alternative approaches to the treatment of tension-type headache.

Sun-Edelstein C, Mauskop A.

Curr Pain Headache Rep. 2012 Dec;16(6):539-44. doi: 10.1007/s11916-012-0295-6. Review.

PMID:
22968473
8.

Nonmedication, alternative, and complementary treatments for migraine.

Mauskop A.

Continuum (Minneap Minn). 2012 Aug;18(4):796-806. doi: 10.1212/01.CON.0000418643.24408.40. Review.

PMID:
22868542
9.

Why all migraine patients should be treated with magnesium.

Mauskop A, Varughese J.

J Neural Transm (Vienna). 2012 May;119(5):575-9. doi: 10.1007/s00702-012-0790-2. Epub 2012 Mar 18. Review.

PMID:
22426836
10.

Predictors of statin adherence.

Mauskop A, Borden WB.

Curr Cardiol Rep. 2011 Dec;13(6):553-8. doi: 10.1007/s11886-011-0221-2. Review.

PMID:
21947789
11.

Alternative headache treatments: nutraceuticals, behavioral and physical treatments.

Sun-Edelstein C, Mauskop A.

Headache. 2011 Mar;51(3):469-483. doi: 10.1111/j.1526-4610.2011.01846.x. Review.

PMID:
21352222
12.

Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Mauskop A.

Neurology. 2010 Oct 12;75(15):1397; author reply 1398-9. doi: 10.1212/WNL.0b013e3181f003be. No abstract available.

PMID:
20938035
13.

Botulinum neurotoxin in the treatment of headache disorders.

Mauskop A.

Handb Clin Neurol. 2010;97:217-32. doi: 10.1016/S0072-9752(10)97017-6.

PMID:
20816423
14.

Foods and supplements in the management of migraine headaches.

Sun-Edelstein C, Mauskop A.

Clin J Pain. 2009 Jun;25(5):446-52. doi: 10.1097/AJP.0b013e31819a6f65. Review.

PMID:
19454881
15.

Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology.

Mauskop A, Mathew N.

Neurology. 2009 Apr 14;72(15):1367; author reply 1367-8. doi: 10.1212/WNL.0b013e3181a53375. No abstract available. Erratum in: Neurology. 2009 Aug 18;73(7):573.

PMID:
19365063
16.

Role of magnesium in the pathogenesis and treatment of migraine.

Sun-Edelstein C, Mauskop A.

Expert Rev Neurother. 2009 Mar;9(3):369-79. doi: 10.1586/14737175.9.3.369. Review.

PMID:
19271946
17.

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel.

J Pain. 2009 Feb;10(2):113-30. doi: 10.1016/j.jpain.2008.10.008.

18.

Complementary and alternative approaches to the treatment of tension-type headache.

Sun-Edelstein C, Mauskop A.

Curr Pain Headache Rep. 2008 Dec;12(6):447-50. Review.

PMID:
18973739
19.

Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.

Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.

Headache. 2008 Feb;48(2):226-35. Epub 2007 Nov 13.

PMID:
18005144
20.

Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies.

Cady R, Martin V, Mauskop A, Rodgers A, Hustad C, Ramsey K, Skobieranda F.

Cephalalgia. 2007 Sep;27(9):1055-60. Epub 2007 Aug 6.

PMID:
17681023

Supplemental Content

Loading ...
Support Center